P62/SQSTM1 is required for cell survival of apoptosis‐resistant bone metastatic prostate cancer cell lines. Issue 2 (30th September 2013)
- Record Type:
- Journal Article
- Title:
- P62/SQSTM1 is required for cell survival of apoptosis‐resistant bone metastatic prostate cancer cell lines. Issue 2 (30th September 2013)
- Main Title:
- P62/SQSTM1 is required for cell survival of apoptosis‐resistant bone metastatic prostate cancer cell lines
- Authors:
- Chang, Megan A.
Morgado, Micaela
Warren, Curtis R.
Hinton, Cimona V.
Farach‐Carson, Mary C.
Delk, Nikki A. - Abstract:
- <abstract abstract-type="main" xml:lang="en"> <title>Abstract</title> <sec id="pros22737-sec-0001" sec-type="section"> <title>BACKGROUND</title> <p>Bone marrow stromal cell (BMSC) paracrine factor(s) can induce apoptosis in bone metastatic prostate cancer (PCa) cell lines. However, the PCa cells that escape BMSC‐induced apoptosis can upregulate cytoprotective autophagy.</p> </sec> <sec id="pros22737-sec-0002" sec-type="section"> <title>METHODS</title> <p>C4‐2, C4‐2B, MDA PCa 2a, MDA PCa 2b, VCaP, PC3, or DU145 PCa cell lines were grown in BMSC conditioned medium and analyzed for mRNA and/or protein accumulation of p62 (also known as sequestome‐1/SQSTM1), Microtubule‐associated protein 1 light chain 3B (LC3B), or lysosomal‐associated membrane protein 1 (LAMP1) using quantitative polymerase chain reaction (QPCR), Western blot, or immunofluorescence. Small interfering RNA (siRNA) was used to determine if p62 is necessary PCa cell survival.</p> </sec> <sec id="pros22737-sec-0003" sec-type="section"> <title>RESULTS</title> <p>BMSC paracrine signaling upregulated <italic>p62</italic> mRNA and protein in a subset of the PCa cell lines. The PCa cell lines that were insensitive to BMSC‐induced apoptosis and autophagy induction had elevated basal <italic>p62</italic> mRNA and protein. In the BMSC‐insensitive PCa cell lines, siRNA knockdown of <italic>p62</italic> was cytotoxic and immunostaining showed peri‐nuclear clustering of autolysosomes. However, in the BMSC‐sensitive PCa cell<abstract abstract-type="main" xml:lang="en"> <title>Abstract</title> <sec id="pros22737-sec-0001" sec-type="section"> <title>BACKGROUND</title> <p>Bone marrow stromal cell (BMSC) paracrine factor(s) can induce apoptosis in bone metastatic prostate cancer (PCa) cell lines. However, the PCa cells that escape BMSC‐induced apoptosis can upregulate cytoprotective autophagy.</p> </sec> <sec id="pros22737-sec-0002" sec-type="section"> <title>METHODS</title> <p>C4‐2, C4‐2B, MDA PCa 2a, MDA PCa 2b, VCaP, PC3, or DU145 PCa cell lines were grown in BMSC conditioned medium and analyzed for mRNA and/or protein accumulation of p62 (also known as sequestome‐1/SQSTM1), Microtubule‐associated protein 1 light chain 3B (LC3B), or lysosomal‐associated membrane protein 1 (LAMP1) using quantitative polymerase chain reaction (QPCR), Western blot, or immunofluorescence. Small interfering RNA (siRNA) was used to determine if p62 is necessary PCa cell survival.</p> </sec> <sec id="pros22737-sec-0003" sec-type="section"> <title>RESULTS</title> <p>BMSC paracrine signaling upregulated <italic>p62</italic> mRNA and protein in a subset of the PCa cell lines. The PCa cell lines that were insensitive to BMSC‐induced apoptosis and autophagy induction had elevated basal <italic>p62</italic> mRNA and protein. In the BMSC‐insensitive PCa cell lines, siRNA knockdown of <italic>p62</italic> was cytotoxic and immunostaining showed peri‐nuclear clustering of autolysosomes. However, in the BMSC‐sensitive PCa cell lines, <italic>p62</italic> siRNA knockdown was not appreciably cytotoxic and did not affect autolysosome subcellular localization.</p> </sec> <sec id="pros22737-sec-0004" sec-type="section"> <title>CONCLUSIONS</title> <p>A pattern emerges wherein the BMSC‐sensitive PCa cell lines are known to be osteoblastic and express the androgen receptor, while the BMSC‐insensitive PCa cell lines are characteristically osteolytic and do not express the androgen receptor. Furthermore, BMSC‐insensitive PCa may have evolved a dependency on p62 for cell survival that could be exploited to target and kill these apoptosis‐resistant PCa cells in the bone. <italic>Prostate 74:149–163, 2014</italic>. © 2013 Wiley Periodicals, Inc.</p> </sec> </abstract> … (more)
- Is Part Of:
- Prostate. Volume 74:Issue 2(2014)
- Journal:
- Prostate
- Issue:
- Volume 74:Issue 2(2014)
- Issue Display:
- Volume 74, Issue 2 (2014)
- Year:
- 2014
- Volume:
- 74
- Issue:
- 2
- Issue Sort Value:
- 2014-0074-0002-0000
- Page Start:
- 149
- Page End:
- 163
- Publication Date:
- 2013-09-30
- Subjects:
- Prostate -- Diseases -- Periodicals
616 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1097-0045 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/pros.22737 ↗
- Languages:
- English
- ISSNs:
- 0270-4137
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6935.194000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 3582.xml